What is Pfizer's allowance for doubtful accounts?

Pfizer (PFE) reported allowance for doubtful accounts of $425M in Q1 2026.

How has Pfizer's allowance for doubtful accounts changed year-over-year?

Pfizer's allowance for doubtful accounts decreased by 0.5% year-over-year, from $427M to $425M.

What is the long-term trend for Pfizer's allowance for doubtful accounts?

Over 5 years (2020 to 2025), Pfizer's allowance for doubtful accounts has grown at a -3.4% compound annual growth rate (CAGR), from $508M to $427M.

Pfizer PFE Allowance for doubtful accounts

Allowance for doubtful accounts at other companies

Merck & Co.MRK

——

BiogenBIIB

——

AbbottABT

——

Gilead SciencesGILD

——

Other financials

Income statement

See full

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

See full

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+5.0%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

See full

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation

See full

Market cap$143.68B+11.1%

Enterprise value$206.35B+9.2%

P/E11.9×—

P/S2.3×+0.2×

Profitability

See full

Gross margin73.5%+1.2pp

Net margin15.7%—

Returns & leverage

See full

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pfizer's allowance for doubtful accounts?: Pfizer (PFE) reported allowance for doubtful accounts of $425M in Q1 2026.
How has Pfizer's allowance for doubtful accounts changed year-over-year?: Pfizer's allowance for doubtful accounts decreased by 0.5% year-over-year, from $427M to $425M.
What is the long-term trend for Pfizer's allowance for doubtful accounts?: Over 5 years (2020 to 2025), Pfizer's allowance for doubtful accounts has grown at a -3.4% compound annual growth rate (CAGR), from $508M to $427M.